Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition

Hong AL, Tseng YY, Wala JA, Kim WJ, Bryan D Kynnap, Doshi MB, Kugener G, Sandoval GJ, Howard TP, Li J, Yang X, Tillgren M, Ghandi M, Sayeed A, Deasy R, Ward A, McSteen B, Labella KM, Keskula P, Tracy A, Connor C, Clinton CM, Church AJ, Crompton BD, Janeway KA, Van Hare B, Sandak D, Gjoerup O, Bandopadhayay P, Clemons PA, Schreiber SL, Root DE, Gokhale PC, Chi SN, Mullen EA, Roberts CW, Kadoch C, Beroukhim R, Ligon KL, Boehm JS, William C Hahn. “Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition”. 2019 Mar 12;8:e44161. PMCID: PMC6436895